1201P The role of a mini tumour mutational burden (TMB) score generated with a customized NGS panel to predict benefit from immunotherapy

Autor:	J.M. Cejalvo, P. Rentero-Garrido, E. Seda, Andrés Cervantes, A. Insa Molla, Pasquale Lombardi, J. Montón-Bueno, J.A. Carbonell-Asins, G. Bruixola, Inés González-Barrallo, S. Zúñiga-Trejos, T. Fleitas, P. Martín-Martorell, S. Blesa, J. Martín-Arana, R. Tébar-Martínez, Jose Alejandro Perez-Fidalgo, Valentina Gambardella, N. Tarazona, Desamparados Roda
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty business.industry Internal medicine medicine.medical_treatment medicine Hematology Immunotherapy business
Zdroj:	Annals of Oncology. 31:S789
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::bdaf0d0877e64d50a9cc37beffc1bf5d https://doi.org/10.1016/j.annonc.2020.08.095 Zobrazit plný text záznamu